3032. PCR. HPV HCR (genotyping, 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, 68, U/G scraping, quantification)
Turnaround time (days): 3
1150 ₴
Description
HPV (human papillomavirus) is a virus from the papillomavirus family that is tropic to skin cells and mucous membranes. Among human papillomaviruses, many genotypes are distinguished, 15 of which are considered highly oncogenic (can provoke the development of cancer).
Quantification of these virus genotypes makes it possible to assess the risk of developing HPV-associated oncological diseases in a patient, and genotyping to determine the virus genotype with high accuracy, which is important for choosing the right treatment tactics.
When and who needs the test?
- all women over 25 to assess the risk of developing cervical cancer
- detection of papillomavirus infection of high oncogenic risk
- confirmation/switching off the persistence of a certain type of HPV
- assessment of the degree of carcinogenic risk in women with dysplasia of the cervical epithelium
- the presence of pathology of the cervix
Biological material
- Scrapes from various sites depending on the test
Preparing for urogenital sampling
Women
- Collection of material should be carried out before the start of treatment with antibacterial/antimycotic drugs (general and local).
- In case of treatment monitoring – 14 days after completion of the course of treatment with antibacterial/antimycotic drugs.
- Avoid sexual intercourse for 3 days.
- In case...
Cheaper in a package